Ginkgo Bioworks Holdings Inc (DNA)
7.285
-1.32
(-15.29%)
USD |
NYSE |
Nov 14, 16:00
7.37
+0.08
(+1.17%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Shareholders Equity (Quarterly): 833.07M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 833.07M |
| March 31, 2024 | 987.27M |
| December 31, 2023 | 1.097B |
| September 30, 2023 | 1.253B |
| June 30, 2023 | 1.504B |
| March 31, 2023 | 1.608B |
| December 31, 2022 | 1.736B |
| Date | Value |
|---|---|
| September 30, 2022 | 1.435B |
| June 30, 2022 | 1.535B |
| March 31, 2022 | 1.581B |
| December 31, 2021 | 1.505B |
| September 30, 2021 | 1.552B |
| December 31, 2020 | 461.38M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
461.38M
Minimum
Dec 2020
1.736B
Maximum
Dec 2022
1.314B
Average
1.504B
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp | 20.71B |
| UnitedHealth Group Inc | 94.54B |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.625B |
| Total Liabilities (Quarterly) | 792.18M |
| Current Ratio | 4.715 |